Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexRUT P/E127.68 EPS (ttm)0.06 Insider Own11.32% Shs Outstand36.83M Perf Week6.51%
Market Cap281.36M Forward P/E- EPS next Y-0.65 Insider Trans7.52% Shs Float32.66M Perf Month7.33%
Income6.54M PEG12.77 EPS next Q-0.29 Inst Own63.99% Short Float7.17% Perf Quarter49.51%
Sales128.44M P/S2.19 EPS this Y-387.50% Inst Trans43.03% Short Ratio13.74 Perf Half Y46.35%
Book/sh-0.13 P/B- EPS next Y29.35% ROA2.32% Short Interest2.34M Perf Year26.20%
Cash/sh0.15 P/C50.97 EPS next 5Y10.00% ROE17.29% 52W Range3.68 - 8.90 Perf YTD22.94%
Dividend Est.- P/FCF- EPS past 5Y86.82% ROI3.81% 52W High-14.49% Beta0.99
Dividend TTM- Quick Ratio0.80 Sales past 5Y-16.64% Gross Margin34.65% 52W Low106.83% ATR (14)0.42
Dividend Ex-Date- Current Ratio1.83 EPS Y/Y TTM106.74% Oper. Margin-7.52% RSI (14)61.12 Volatility6.59% 6.43%
Employees524 Debt/Eq3.46 Sales Y/Y TTM4.88% Profit Margin5.09% Recom2.33 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq3.34 EPS Q/Q-48.71% Payout0.00% Rel Volume0.83 Prev Close7.58
Sales Surprise6.54% EPS Surprise-8.90% Sales Q/Q0.75% EarningsOct 04 BMO Avg Volume170.53K Price7.61
SMA204.29% SMA5021.36% SMA20029.86% Trades Volume141,778 Change0.40%
Date Action Analyst Rating Change Price Target Change
Sep-05-24Initiated Craig Hallum Buy $8
Aug-28-24Downgrade Barrington Research Outperform → Mkt Perform
Mar-20-23Downgrade Stephens Overweight → Equal-Weight $11 → $2
Dec-12-24 10:03AM
Nov-26-24 04:05PM
Nov-21-24 04:17PM
Nov-15-24 08:44AM
Nov-12-24 04:05PM
07:00AM Loading…
Nov-07-24 07:00AM
Nov-04-24 07:00AM
Oct-17-24 07:30AM
Oct-07-24 09:12PM
01:00AM
Oct-04-24 07:52AM
07:30AM
07:20AM
Oct-03-24 04:05PM
Oct-01-24 07:00AM
04:05PM Loading…
Sep-25-24 04:05PM
Sep-19-24 07:00AM
Sep-12-24 04:05PM
07:00AM
Sep-10-24 07:00AM
Sep-06-24 04:05PM
Sep-05-24 04:05PM
Aug-29-24 07:00AM
Aug-27-24 11:59PM
Aug-26-24 05:23PM
Aug-09-24 05:51PM
Jul-26-24 03:30AM
Jul-11-24 02:51AM
Jul-01-24 08:00AM
May-22-24 04:16PM
04:45PM Loading…
May-16-24 04:45PM
May-08-24 12:26PM
May-03-24 03:31AM
02:44AM
Apr-22-24 10:59AM
10:29AM
Apr-19-24 04:30PM
Apr-11-24 02:21AM
Apr-01-24 08:00AM
Mar-26-24 04:30PM
Mar-21-24 12:40PM
Mar-20-24 07:30AM
07:00AM
Feb-16-24 04:05PM
Feb-06-24 09:49AM
Jan-30-24 12:20AM
Jan-12-24 04:43PM
Jan-08-24 03:05AM
Jan-05-24 08:00AM
Dec-13-23 07:30AM
Nov-20-23 04:05PM
Nov-17-23 06:04PM
Oct-24-23 07:48AM
Oct-18-23 04:05PM
Oct-17-23 05:00AM
Oct-10-23 04:05PM
08:43AM
Sep-28-23 10:00AM
Sep-01-23 10:44AM
Aug-31-23 10:15PM
08:50AM
07:54AM
07:30AM
Aug-22-23 04:06PM
04:05PM
Aug-18-23 06:30PM
Aug-17-23 08:15AM
Aug-16-23 01:02AM
Aug-12-23 12:33AM
Jul-31-23 05:08AM
Jul-22-23 08:19AM
Jul-12-23 08:48AM
Jul-07-23 11:40AM
Jun-29-23 06:37AM
Jun-08-23 07:30AM
Jun-03-23 08:13AM
Jun-02-23 01:53AM
Jun-01-23 07:23AM
07:15AM
May-26-23 06:20AM
May-22-23 04:51PM
04:49PM
06:55AM
Apr-17-23 07:26AM
Apr-14-23 04:35PM
Apr-11-23 02:25AM
Apr-06-23 04:05PM
Mar-17-23 09:53PM
Mar-16-23 04:24PM
04:23PM
04:21PM
Feb-16-23 08:22AM
Feb-07-23 04:30PM
Jan-12-23 08:01AM
Jan-11-23 04:35PM
Jan-09-23 04:05PM
Dec-28-22 12:17PM
Dec-23-22 07:29AM
Dec-08-22 05:26AM
Nov-25-22 04:50PM
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morberg John DFormer officerNov 20 '24Proposed Sale7.1710,00071,691Nov 20 10:14 AM
Morberg John DFormer officerNov 11 '24Proposed Sale6.6430,990205,803Nov 12 02:43 PM
Morberg John DFormer officerOct 31 '24Proposed Sale5.6840,989232,888Oct 31 04:18 PM
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerOct 03 '24Buy4.10169,753695,9872,607,433Oct 07 08:45 PM
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerOct 03 '24Buy4.10122,930504,0132,095,783Oct 07 08:45 PM
Morberg John DFormer officerOct 07 '24Proposed Sale5.1912,61765,482Oct 07 01:03 PM
Morberg John DFormer officerSep 20 '24Proposed Sale5.4915,00082,350Sep 20 04:00 PM